Trajectory of Immunosuppression-Caused Tremor In Kidney and Lung Transplant Recipients

NCT06488651 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2025-09-15

No results posted yet for this study

Summary

Kidney and lung transplant recipients have to adhere to a strict immunosuppressive maintenance regime, generally consisting of calcineurin inhibitors (CNI). Tremor is a common and distressing side effect of CNI-use. To what extent objective and/or subjective tremor changes over time in currently unknown. Therefore, this longitudinal prospective study aimed to assess the course of tremor in the first year after transplantation.

Conditions

  • Kidney Transplantation
  • Tremor

Sponsors & Collaborators

  • University Medical Center Groningen

    lead OTHER

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-17
Primary Completion
2025-09-12
Completion
2025-09-12

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06488651 on ClinicalTrials.gov